Trekka Therapeutics, LLC
Publicly observedSaint Paul, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Saint Paul | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Trekka Therapeutics, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | DQNYYX2KMPK6 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant4 Sept 2025Publicly observed
NIH SBIR/STTR award: Nanodroplet Infused Analgesic-Wafer for Transmucosal Opioid-free Treatment of Subacute Oral Pain
USD 283,223.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
- Grant4 Sept 2025Publicly observed
NIH SBIR/STTR award: Nanodroplet Infused Analgesic-Wafer for Transmucosal Opioid-free Treatment of Subacute Oral Pain
USD 413,298.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.